The largest database of trusted experimental protocols

Spectrafluor plus plate reader

Manufactured by Tecan
Sourced in Austria, Switzerland

The Spectrafluor Plus plate reader is a versatile instrument designed for fluorescence-based measurements. It features a high-performance optical system and provides accurate and sensitive detection of fluorescent signals in multi-well microplates. The Spectrafluor Plus is capable of performing a range of fluorescence-based assays, making it a useful tool for researchers in various scientific fields.

Automatically generated - may contain errors

24 protocols using spectrafluor plus plate reader

1

Quantification of Soluble TREM-1 and Inflammatory Mediators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Soluble (s)TREM-1 was quantified in cell-free Mf supernatants by human TREM-1 DuoSet (R&D Systems). Secreted IL-12, TNFα, IL-1β, CXCL8, IL-6, and IL-10 (Peprotech, Milano), osteopontin (OPN), CCL18, CCL24 and TGFβ1 (R&D Systems, Space Import Export, Milano, Italy) content in Mf CM was also measured by specific ELISA. HMGB1 levels were measured in SF and plasma from OJIA patients and age-matched controls using HMGB1 ELISA kit II (IBL International, Hamburg, Germany); the lower limit of detection was 0.3 ng/mL. Optical density was determined using a Spectrafluor Plus plate reader from TECAN (Milano, Italy). All assays were done in duplicate.
+ Open protocol
+ Expand
2

3D Spheroid Viability Assay for DU145 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The DU145 cell line was seeded into Nunclon Sphera 96-well U-bottom plates (Thermo Scientific) with 5,000 cells/well in a 50 mL volume of opti-MEM supplemented with 2% FBS, 100 U penicillin, and 100 mg/mL streptomycin (opti-MEM). After 48 h an additional 50 mL volume of media was added. The cells were incubated for an additional 4 d, whereupon the cells formed spheroids with an average diameter of 450 mm. Visual inspection was used to ensure that the spheroids were uniform in size and shape across all wells. Compounds were prepared in opti-MEM, added to the spheroids, followed by a further incubation of 72 h. Viability was measured with the Cell Titer Glo 3D Viability Assay (Promega), where an equal volume of Cell Titer Glo was added to each well, followed by titrating the solution 3–4 times to disrupt the spheroids. The solution was then transferred to a 96-well plate and luminescence measured with the SpectraFluor Plus plate reader (Tecan).
+ Open protocol
+ Expand
3

Photocytotoxicity Assay for Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human alveolar adenocarcinoma
cell line A549, Human promyelocytic leukemia cell line HL60, and Human
T lymphocyte cell line Jurkat cells were maintained in media supplemented
with 10% FBS and 50 U/mL pen-strep at 37 °C with 5% CO2, with DMEM used for A549 cells and IMDM and RPMI 1640 used for HL60
and Jurkat cells, respectively. Cells were assayed in Opti-MEM supplemented
with 1% serum supreme and 50 U/mL pen-strep and seeded into 96 well
plates at a density of 1.5 × 103 cells/well for A549,
2 × 104 cells/well for HL60, and 1 × 104 cells/well for Jurkat followed by a 6 h incubation at 37 °C,
5% CO2. Cells were then dosed with serial dilutions of
compound and incubated for 18 h. They were then irradiated with 7
J/cm2 light (>400 nm) in 30 s pulses or kept in the
dark.
Cell viability was determined 72 h later by measuring the conversion
of resazurin to resorufin,45 (link) using a SpectraFluor
Plus Plate Reader (Tecan).
+ Open protocol
+ Expand
4

Coumarin-7-boronic acid fluorescence assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
BV2 cells were grown in phenol-free DMEM medium as mentioned above. Cells were incubated with LPS (500 ng/ml) for 21 hours and then coumarin-7-boronic acid was added (20 µM); fluorescence intensities were monitored immediately after coumarin-7-boronic acid addition using a Tecan SpectraFluor-Plus plate reader (Research Triangle Park, NC) equipped with the appropriate excitation (320 nm) and emission (430 nm) filters. The instrument was prewarmed and kept at 37°C during measurements, and fluorescence intensity read from the top of each well was recorded every 10 minutes for 180 minutes. In other experiments, cells were incubated with LPS (500 ng/ml) and TNFα (50 ng/ml) for 21 hours, and then co-treated with coumarin-7-boronic acid and PMA (200 ng/ml) in the same medium before monitoring fluorescence.
+ Open protocol
+ Expand
5

Cytotoxicity Assessment of Compounds in A549 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human alveolar
adenocarcinoma A549
cells were maintained in DMEM, supplemented with 10% FBS and 50 U/mL
pen-strep at 37 °C with 5% CO2. A549 cells were assayed
in Opti-MEM supplemented with 1% serum supreme and 50 U/mL pen-strep
and seeded into 96 well plates at a density of 1.5 × 103 cells/well followed by a 6 h incubation at 37 °C, 5% CO2. Cells were then dosed with serial dilutions of compound
and incubated for 48 h. Cell viability was determined by measuring
the conversion of resazurin to resorufin35 (link) using a SpectraFluor Plus Plate Reader (Tecan). Data were fit to
an equation for a sigmoidal dose response using the equation below,
where yi and yf are the initial and final signal
intensities.
For comparison purposes,
the cytotoxicity
of CDDP was evaluated under the same experimental conditions. All
compounds were tested in three independent studies with quadruplicate
points. The compounds were dissolved in water, except 5, which was dissolved in DMSO and diluted in the culture medium so
that the final % DMSO was 0.4.
+ Open protocol
+ Expand
6

Cytotoxicity Evaluation of Platinum Complexes in 3D MCTSs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 MCTSs (diameter 600
μm) were treated by carefully replacing 50% of the medium with
drug-supplemented standard medium by using an eight-channel pipet.
In parallel, 50% of the solvent-containing medium was replaced by
solvent-free medium for the untreated MCTSs. Three MCTSs were treated
per condition and drug concentration, and the DMSO volume was less
than 1% (v/v). The MCTSs were then allowed to incubate for another
48 h. The cytotoxicity of the platinum complexes toward the MCTSs
was measured by the adenosine triphosphate (ATP) concentration with
the Cell TiterGlo kit (Promega). After 30 min of incubation, the MCTSs
were carefully transferred into black-sided, flat-bottomed 96-well
plates (Corning) and mixed with a pipet for luminescence measurements
on a SpectraFluor Plus Plate Reader (TECAN). Data were fit to an equation
for sigmoidal dose response shown above using the Prism software package.
+ Open protocol
+ Expand
7

Cytotoxicity of Platinum Complexes on A549 MCTSs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A549 MCTSs (diameter 600 μm) were treated by carefully replacing 50% of the medium with drug-supplemented standard medium by using an eight-channel pipette. In parallel, 50% of the solvent-containing medium was replaced by solvent-free medium for the untreated MCTSs. Three MCTSs were treated per condition and drug concentration, and the DMSO volume was less than 1% (v/v). The MCTSs were then allowed to incubate for another 48 h. The cytotoxicity of the platinum complexes toward the MCTSs was measured by the adenosine triphosphate (ATP) concentration with the Cell TiterGlo kit (Promega). After 30 min of incubation, the MCTSs were carefully transferred into black-sided, flat-bottomed 96-well plates (Corning) and mixed with a pipette for luminescence measurements on a SpectraFluor Plus Plate Reader (TECAN). Data were fit to an equation for sigmoidal dose response shown above using the Prism software package.
+ Open protocol
+ Expand
8

Cytotoxicity Evaluation of Compounds on A549 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human alveolar adenocarcinoma A549 cells were maintained in DMEM, supplemented with 10% FBS and 50 U/mL pen-strep at 37 °C with 5% CO2. A549 cells were assayed in Opti-MEM supplemented with 1% serum supreme and 50 U/mL pen-strep and seeded into 96 well plates at a density of 1.5 × 103 cells/well followed by a 6 h incubation at 37 °C, 5% CO2. Cells were then dosed with serial dilutions of compound and incubated for 48 h. Cell viability was determined by measuring the conversion of resazurin to resorufin35 (link) using a SpectraFluor Plus Plate Reader (Tecan). Data were fit to an equation for a sigmoidal dose response using the equation below, where yi and yf are the initial and final signal intensities.
y=yi+yiyf1+10(logEC50x)Hillslope
For comparison purposes, the cytotoxicity of CDDP was evaluated under the same experimental conditions. All compounds were tested in three independent studies with quadruplicate points. The compounds were dissolved in water, except 5, was dissolved in DMSO and diluted in the culture medium so that the final %DMSO was 0.4.
+ Open protocol
+ Expand
9

Quantification of Carbohydrates and Amino Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Carbohydrates: For the extraction of starch and soluble sugars lyophilized leaf material was treated as described in (Lin et al., 1988 (link)) and determined with a coupled enzymatic assay (Stitt et al., 1989 (link)) in a Spectrafluor Plus plate reader (TECAN, Austria) in the absorbance mode.
Amino acids: Lyophilized tissue (2–8 mg) was homogenized by a TissueLyser (Quiagen) at 23 Hz for 30 s and subsequently extracted with 300 μl of 80% EtOH at 4°C for 20 min on an orbital shaker. The mixture was centrifuged at 21000 × g for 5 min at 4°C and the supernatants were transferred to fresh 2 ml test tubes, while the debris was extracted with 200 μl 96% EtOH and again incubated at 4°C for 20 min on an orbital shaker. Following centrifugation at 21000 × g for 5 min at 4°C the second supernatants were unified with the first ones in the 2 ml test tubes. The analysis of free amino acid contents was carried out as outlined in Krueger et al. (2017) (link) by reversed phase HPLC using a HyperCloneTM 5 μm ODS (C18) column (Phenomenex). The samples were precolumn-derivatized with o-phthalaldehyde according Lindroth and Mopper (1979) (link).
+ Open protocol
+ Expand
10

VCAM-1 Mediated Cell Adhesion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell adhesion
assay was carried
out as previously described47 (link) with minor
modifications. The day before the experiment, each well was coated
with VCAM-1 (3 mg/mL) immobilized on the 96-well plate in PBS by overnight
incubation at 4 °C. Thereafter, nonspecific binding was blocked
by incubating the wells with 1% (w/v) bovine serum albumin (BSA) in
Hank’s Balanced Salt Solution (HBSS) containing 5 mM MgCl2 at room temperature for 1 h before use. The cells were labeled
by incubation with 12.5 μM 5-chloromethylfluorescein diacetate
(CMFDA) in HBSS without 1% BSA at 37 °C for 30 min. The labeled
cells were then centrifuged at 1000 rpm and washed twice with HBSS
containing 1% BSA to remove excess CMFDA. Labeled cells (about 1 ×
105 cells/well) were plated on each well in the presence
or absence of visabrons and incubated at 37 °C for 60 min. Unbound
cells were removed by washing the wells three times with 1% (w/v)
BSA in HBSS, and bound cells were lysed by the addition of 0.5% Triton
X-100 (diluted in DDW). The fluorescence in each well was quantified
with a SPECTRAFluor Plus plate reader (Tecan), at λex = 485 nm and λem = 530 nm. To determine the number
of adhered cells from the fluorescence values, a standard curve was
generated by serial dilution of known numbers of CMFDA-labeled cells.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!